Overview
ISO 10993-18:2020/Amd 1:2022 is an important amendment to the international standard for the biological evaluation of medical devices, specifically addressing the chemical characterization of medical device materials within a risk management process. This amendment focuses on the determination of the uncertainty factor (UF), a key element in analytical quantification related to extractables and leachables from medical device materials. By refining how uncertainty factors are calculated and applied, the document enhances the precision and reliability of chemical evaluations tied to toxicological risk assessments.
ISO 10993-18 forms part of the ISO 10993 series, which establishes principles and guidance for evaluating the biological safety of medical devices. This amendment provides critical updates to improve the chemical characterization process, essential for ensuring patient safety and regulatory compliance.
Key Topics
-
Uncertainty Factor (UF) Determination
The amendment details how to calculate and apply the uncertainty factor when estimating concentrations of extractable substances. UF accounts for variability in analytical response factors across different compounds, ensuring conservative and scientifically justified safety thresholds.
-
Analytical Quantification Methods
Discussion covers various quantification strategies such as use of substitution standards, authentic calibration curves, and relative response factors. Each method’s impacts on concentration accuracy and the necessity to adjust thresholds through UF are clarified.
-
Risk Management Integration
Chemical characterization is embedded within a risk management process, aiming to identify and control risks related to chemical exposure from medical device materials.
-
Statistical Approach to UF
A formula linking the UF to the relative standard deviation (RSD) of response factors is described. This statistical grounding ensures scientifically robust adjustment of evaluation thresholds based on real analytical variation.
-
Guidance on Method Selection and Optimization
The amendment emphasizes that methods with high variability in response factors may require optimization to reduce uncertainty and improve reliability in toxicological risk assessments.
-
Use of Complementary Analytical Techniques
Employing multiple, orthogonal analytical methods (e.g., GC-MS and LC-MS) is recommended to reduce total uncertainty and better characterize extractables.
Applications
-
Medical Device Safety Assessments
ISO 10993-18:2020/Amd 1:2022 supports device manufacturers and testing laboratories in improving chemical characterization data quality - crucial for establishing safe exposure levels to chemical constituents.
-
Regulatory Submissions and Compliance
Adoption of updated uncertainty factor calculations helps align chemical evaluation reports with regulatory expectations globally, facilitating market access.
-
Analytical Method Development and Validation
Guidance on UF determination assists analytical chemists in designing and validating extraction and quantification methods tailored for medical device materials.
-
Risk-Based Toxicological Evaluations
Integrates chemical data more accurately into toxicological risk models, enabling better decision making in material selection and device design.
-
Quality Control in Manufacturing
Supports ongoing quality assurance by enabling detection and quantification of chemical substances at levels consistent with biologically safe thresholds adjusted for analytical uncertainty.
Related Standards
-
ISO 10993 Series
Covers the broader biological evaluation framework of medical devices, including cytotoxicity, sensitization, and systemic toxicity assessments.
-
ISO/IEC Directives
Governs procedures for the development and maintenance of ISO standards, ensuring consistency and quality.
-
ISO 10993-1
Provides general principles for biological evaluation and risk management applicable across medical device materials.
-
Complementary Analytical Guidance
Relevant publications on extractables and leachables analysis, including orthogonal methods for chemical characterization.
Summary
ISO 10993-18:2020/Amd 1:2022 plays a pivotal role in refining the chemical characterization process in medical device safety evaluation by introducing a rigorous, statistically based approach to calculating uncertainty factors. By addressing analytic variability and improving risk assessment accuracy, this amendment strengthens patient safety, supports regulatory compliance, and advances best practices in medical device development and testing worldwide.
Keywords: ISO 10993-18 amendment, chemical characterization, medical device materials, uncertainty factor determination, extractables and leachables, risk management, analytical quantification, toxicological risk assessment, medical device safety, regulatory compliance, analytical method validation
Open preview (PDF)Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process — Amendment 1: Determination of the uncertainty factor